DE69836278D1 - Allele formen von menschlichem stat3 - Google Patents

Allele formen von menschlichem stat3

Info

Publication number
DE69836278D1
DE69836278D1 DE69836278T DE69836278T DE69836278D1 DE 69836278 D1 DE69836278 D1 DE 69836278D1 DE 69836278 T DE69836278 T DE 69836278T DE 69836278 T DE69836278 T DE 69836278T DE 69836278 D1 DE69836278 D1 DE 69836278D1
Authority
DE
Germany
Prior art keywords
forms
human stat3
human
autoimmune
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69836278T
Other languages
English (en)
Other versions
DE69836278T2 (de
Inventor
Ottaviano Serlupi-Crescenzi
Pietra Linda Della
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97116061A external-priority patent/EP0906953A1/de
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of DE69836278D1 publication Critical patent/DE69836278D1/de
Publication of DE69836278T2 publication Critical patent/DE69836278T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69836278T 1997-09-16 1998-09-15 Allele formen von menschlichem stat3 Expired - Fee Related DE69836278T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP97116061 1997-09-16
EP97116061A EP0906953A1 (de) 1997-09-16 1997-09-16 Allele Formen von menschlicher STAT3
EP98102774A EP0905234A3 (de) 1997-09-16 1998-02-18 Allele Formen vom Menschlicher STAT3
EP98102774 1998-02-18
PCT/EP1998/005844 WO1999014322A2 (en) 1997-09-16 1998-09-15 Allelic variant of human stat3

Publications (2)

Publication Number Publication Date
DE69836278D1 true DE69836278D1 (de) 2006-12-07
DE69836278T2 DE69836278T2 (de) 2007-09-13

Family

ID=26145781

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836278T Expired - Fee Related DE69836278T2 (de) 1997-09-16 1998-09-15 Allele formen von menschlichem stat3

Country Status (10)

Country Link
US (2) US6369198B1 (de)
EP (2) EP0905234A3 (de)
JP (1) JP2001516578A (de)
AT (1) ATE343633T1 (de)
AU (1) AU9743698A (de)
DE (1) DE69836278T2 (de)
DK (1) DK1012286T3 (de)
ES (1) ES2272010T3 (de)
PT (1) PT1012286E (de)
WO (1) WO1999014322A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391572B1 (en) 1999-08-31 2002-05-21 The Rockefeller University Methods for identifying modulators of transcriptional activator protein interactions
US7094140B2 (en) * 2003-06-03 2006-08-22 Onfloor Technologies, L.L.C. Abrasive sanding surface
US20060148715A1 (en) * 2004-12-20 2006-07-06 Baylor College Of Medicine Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands
JP5495249B2 (ja) 2009-02-23 2014-05-21 富士通株式会社 新規化合物、リン酸化阻害剤、インスリン抵抗性改善剤、及び糖尿病の予防乃至治療剤、並びに、スクリーニング方法
US20130177979A1 (en) * 2010-06-22 2013-07-11 University Of Central Florida Research Foundation, Inc. Methods and compositions for cell permeable stat3 inhibitor
EP2723892A2 (de) * 2011-06-27 2014-04-30 Galderma Research & Development Neue th-17-differenzierungsmarker für rosacea und ihre verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2172490A1 (en) * 1993-09-24 1995-03-30 James E. Darnell, Jr. Receptor recognition factors, protein sequences and methods of use thereof
EP0676469A3 (de) * 1994-04-04 1998-03-25 Tadamitsu Kishimoto Transkriptionsfaktor APRF
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription

Also Published As

Publication number Publication date
ES2272010T3 (es) 2007-04-16
EP1012286B1 (de) 2006-10-25
DE69836278T2 (de) 2007-09-13
EP0905234A2 (de) 1999-03-31
US20030166854A1 (en) 2003-09-04
JP2001516578A (ja) 2001-10-02
WO1999014322A3 (en) 1999-08-05
PT1012286E (pt) 2006-12-29
EP0905234A3 (de) 1999-06-23
DK1012286T3 (da) 2007-02-12
US6369198B1 (en) 2002-04-09
AU9743698A (en) 1999-04-05
EP1012286A2 (de) 2000-06-28
ATE343633T1 (de) 2006-11-15
US6660848B2 (en) 2003-12-09
WO1999014322A2 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
WO1996034953A3 (en) Cd16-ii variants
FI971756A (fi) CD23:een sitoutuvia aineita
ATE232396T1 (de) Oxydiertes thymosin beta 4
DE19975063I1 (de) DNS den menschlichen Tumornekrosisfaktor kodierendund das menschliche Tumornekronisfaktor-Polypeptid.
SE9802729D0 (sv) Novel Compounds
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
SE9904377D0 (sv) Pharmaceutical combinations
NO20006113L (no) Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer
DE69836278D1 (de) Allele formen von menschlichem stat3
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DE69634044D1 (de) Menschliches cyclin i und das dafuer kodierende gen
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
DE69817860D1 (de) Für die i45f-mutation kodierende human app oder a4ct sequenzen
DE59811703D1 (de) Medizinischer oder dentalmedizinischer Behandlungsstuhl
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ITMI951336A0 (it) Nuovo gene del cromosoma x umano e proteina codificata da detto gene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH

8339 Ceased/non-payment of the annual fee